Key Takeaways
- Soft quarter, guidance held: Revenue came in below HCL’s own expectations, yet management retained its full-year revenue and margin guidance, citing an all-time-high pipeline and a commitment to cost actions.
- Vertical split defines the miss: Financial Services, Manufacturing and Life Sciences grew on large deal execution, while Tech and Telecom declined sharply as discretionary projects failed to go live in the second half of the quarter.
- Discretionary spend is the wildcard: Management believes discretionary spend is stabilizing, but admits the industry is struggling to forecast the drop and that HCL itself has got it wrong a couple of times on that element.
- Margins dipped on utilization and one-offs: Services margin fell 120 bps QoQ, driven by consciously lower utilization held to cater for future large deals, plus travel costs and the reversal of a prior-quarter benefit.
- What to watch next quarter: Whether the promised spike in bookings materializes, whether Tech and Telecom stabilize as expected, and whether cost actions are enough to close the gap to the annual margin target.
Demand Environment
- The Q1 miss: Large deals ramped well and delivered good revenue growth in Life Sciences, Manufacturing and Financial Services, but Tech and Telecom saw more drops than expected, with some projects that were expected to go online in the second half of the quarter not moving forward.
- Discretionary spend volatility: Discretionary spend is moderating and probably stabilizing at a certain level, but cost and efficiency-led programs now need to fill the gap and create net incremental growth. This state has been achieved in Manufacturing, Financial Services and Life Sciences, but other verticals are lagging.
- Forecasting difficulty: The industry itself is struggling to forecast the drop in discretionary spend, and HCL got it wrong a couple of times on that element. There is a lot of volatility in discretionary spend, which is the only element HCL believes it can improve based on the last 2–3 quarters.
- Tech and Telecom exposure: The decline is largely within ER&D but also impacted ITBS. The exposure is primarily to big tech, which has seen a lot of consolidation and rationalization of spend. This consolidation and rationalization appears to be stabilizing now.
- ER&D decision-making: Decision-making, which used to be reasonable, is getting a little delayed, though a growing pipeline of consolidation deals should convert to revenue quicker.
Vijayakumar: "While we expected the quarter to be soft, it came in lower than our own expectations."
Deal Wins & Pipeline
- Pipeline at record levels: Pipeline is at an all-time high, increased 18% QoQ and up 26% YoY, with a healthy mix of large deals in advanced stages. Management expects strong bookings in Q2 and some spikes in coming quarters to make up for the Q1 drop.
- Notable wins: A Fortune 50 healthcare company selected HCLTech for end-to-end IT infrastructure modernization; a global financial services company for digital transformation to hybrid cloud; a US-based healthcare company for one of the largest deals, exceeding $250 million.
- Software momentum: A large Asian stock exchange selected HCLSoftware’s DX platform; a Euro-based financial services firm expanded its partnership for Unica in Latin America.
Vertical Performance
| Vertical | Trend | Commentary |
|---|---|---|
| Financial Services | ▲ Strong growth | Large deal execution offset discretionary spend reduction. |
| Manufacturing | ▲ Strong growth | Large deal execution offset discretionary spend reduction. |
| Life Sciences | ▲ Strong growth | Large deal execution offset discretionary spend reduction. |
| Tech & Telecom | ▼ Significant decline | Cuts in discretionary spend and associated ramp-downs; exposure primarily to big tech consolidation. Decline appears to be stabilizing. |
- ER&D segment: Two trends are at play: consolidation deals in Tech and Telecom with a growing pipeline that should convert to revenue quicker, and delayed decision-making. HCL expects ER&D to be back into a growth trajectory going forward.
- Tech and Telecom outlook: The decline appears to be stabilized, but given volatility, management cannot give more color. Conversion cycles in R&D are shorter, so HCL expects to perform better in the next quarter.
Margins & Cost Actions
| Margin walk (QoQ) | Impact |
|---|---|
| Lower utilization | –36 bps |
| Travel and one-time costs at beginning of year | –33 bps |
| One-time benefit in prior quarter reversing | –42 bps |
| Net change in Services margin | –120 bps |
- Utilization consciously lowered: HCL kept utilization lower to cater to expected large deals in coming quarters.
- Cost actions underway: The leadership team is committed to taking actions to meet the numbers; the plan has been revised based on Q1 numbers by baking in more actions and cost cutbacks. Management is taking incremental actions to reduce cost to meet margin guidance.
- One-time intangible amortization benefit: This is a one-time benefit from an impairment taken a couple of years back on a product; the product has done well and royalties are significantly up, so per accounting rules the impairment was written back. It will not reverse in Q2.
Vijayakumar: "We do take our commitments very seriously. So, in spite of a weaker performance in Q1, we are confident of delivering to the commitments that we have made."
People & Hiring
- Headcount reduction: Net reduction of ~2,500, primarily from not backfilling attrition; 1,800 freshers added as planned.
- Compensation deferred: HCL skipped the compensation review for the management layer (E4+) and deferred it by a quarter for junior to mid-level (E3 and below), while monitoring industry trends.
- Hiring plans moderated: Hiring plans are moderated quarter-on-quarter to align with revenue forecasts. Q2 is typically when fresher intake is higher, so that will continue as planned; lateral hire requirements will be moderated. Some productivity-based releases are also expected, so HCL is not dependent on a lot of hiring for growth in Q2.
Gen AI & Software
- Gen AI activity: 140+ external and internal Gen AI projects are at various stages. Deployments include a Gen AI voice bot for a healthcare company, enterprise OpenAI search for a federal water corporation, and an intelligent aggregator for pharma and medical devices.
- Contractual positioning: Most Gen AI conversations remain innovation-led. Customers are challenging HCL to demonstrate the art of the possible, but management does not see anyone trying to take a contractual position on how much must be delivered through this technology because there are too many dependencies.
- HCLSoftware go-to-market: A customer success organization, strong renewal focus, and a partner ecosystem with four routes (GSI, Hyperscalers, OEM ISVs, Business partners) are in place; 10% of new license bookings came from partner-generated leads. Gen AI is being infused via HCL PromptO, with Unica and other products creating Gen AI capabilities with Co-pilot and Duet AI.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue guidance | Retain full-year revenue guidance despite Q1 miss | FY24 |
| Margin guidance | Retain full-year margin guidance; taking incremental cost actions to meet it | FY24 |
| Bookings recovery | Expect strong bookings in Q2 and some spikes in coming quarters to make up for Q1 drop | Q2 and beyond |
| Tech and Telecom stabilization | Decline appears to be stabilizing; expect growth to pick up in coming quarters | Coming quarters |
| ER&D recovery | Expect ER&D to be back into a growth trajectory; conversion cycles are shorter, so better performance expected next quarter | Next quarter onward |
| Revenue trajectory | Quarters will get incrementally better; a spike is expected in one of the quarters | FY24 (quarter unspecified) |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Revenue | US$3.2 bn, down 1.3% QoQ, up 6.3% YoY in constant currency |
| Services revenue | US$2.9 bn, down 1% QoQ, up 7.1% YoY in constant currency |
| ITBS revenue growth | Flat QoQ, up 9.1% YoY in constant currency |
| ERS revenue growth | Down 5.2% QoQ in constant currency |
| Software revenue growth | Flat YoY |
| EBIT margin | 17.0%, down 110 bps QoQ from 18.1% |
| Net income | US$430 mn, 13.4% of revenue, up 1.5% YoY |
| Diluted EPS (LTM) | INR 55.70, up 11.3% YoY |
| ROIC (LTM) | 31.1%, up 260 bps YoY; Services 38%, Software 15.9% |
| Revenue growth guidance | 6%–8% in constant currency, retained for FY24 |
| Margin guidance | 18%–19% EBIT, retained for FY24 |
| Bookings | US$1.6 bn, soft quarter; pipeline up 18% QoQ and 26% YoY |
| ACV | 21% lower YoY for the quarter |
| Software ARR growth | 4.7% YoY in constant currency |
| Voluntary attrition (LTM) | 16.3%, down 7.5 ppt YoY |
| Net headcount change | Reduced by ~2,500; added 1,800 freshers |
| Operating cash flow (LTM) | ~US$2.5 bn, 135% of net income |
| Free cash flow (LTM) | US$2.33 bn, 126% of net income |
| Gross cash | US$2.664 bn; net cash ~US$2.4 bn |
| Dividend declared | INR 10 per share |
| Compensation review | Skipped for E4+ management layer; deferred by one quarter for E3 and below |